Joint pain is not acceptable. Simply put, people in pain don’t work out and can become inactive. And considering that our bodies are meant to move, this is definitely not a good thing.
Staying active is one sure way to improve your quality of life and, for most of us, will ultimately translate into a longer life.
New research shows that the antioxidant, ergothioneine, holds promise for relieving joint pain. This means that we could potentially have another weapon in combating arthritis.
Ergothioneine is a Joint-Specific Antioxidant
The science is not conclusive yet, but it's promising. Dr. Bruce N. Ames, senior scientist at the Children’s Hospital Oakland Research Institute, told the website Nutraingredients-USAthat, “Ergothioneine is a very weak antioxidant compared to other … compounds in the cell, which isn’t necessarily a bad thing. Specificity is the key.”1
And Dr. Ames is right. Any time you can target a tissue and deliver a nutrient specifically to that tissue, the effects will be greater than using a nutrient that distributes all over the body — even if that nutrient is stronger than the more specific one. And that’s exactly what you have with ergothioneine: A potentially more joint-specific, antioxidant.
Some doctors actually think ergothioneine might someday be classified as a new human vitamin. Dr. Dirk Gründemann from the University of Cologne in Germany published a paper in 2009 that highlighted its properties as a vitamin. He wrote that it concentrates in the blood by a specific transporter and then is delivered directly into different tissues, like joints.2
Read More:
http://blog.lef.org/2012/05/new-antioxidant-arthritis-pain.html